Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years
- PMID: 38202217
- PMCID: PMC10779530
- DOI: 10.3390/jcm13010210
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years
Abstract
Background: Stent implantation represents the standard of care in coronary intervention. While a short stent implanted on a focal lesion located on the left anterior descending artery (LAD) seems a reasonable alternative to an internal mammary implant, the same for long stents is still debated.
Methods: We reported the long-term data of 531 consecutive patients who underwent Percutaneous Coronary Intervention (PCI) with long stents in two highly specialized centres. The main inclusion criteria were the implantation of stents longer than 30 mm on the LAD and a minimum follow-up (FU) of five years. The primary endpoint was mortality, and the secondary endpoints were any myocardial infarction (MI), target vessel and lesion revascularization (TVR and TLR, respectively), and stent thrombosis (ST) observed as definite, probable, or possible.
Results: In this selected population with characteristics of complex PCI (99.1%), the long-term follow-up (mean 92.18 ± 35.5 months) estimates of all-cause death, cardiovascular death, and any myocardial infarction were 18.3%, 10.5%, and 9.3%, respectively. Both all-cause and cardiovascular deaths are significantly associated with three-vessel disease (HR 6.8; confidence of interval (CI) 95% 3.844-11.934; p < 0.001, and HR 4.7; CI 95% 2.265-9.835; p < 0.001, respectively). Target lesion (TLR) and target vessel revascularization (TVR) are associated with the presence of three-lesion disease on the LAD (HR 3.4; CI 95% 1.984-5.781; p < 0.001; HR 3.9 CI 95% 2.323-6.442; p < 0.001, respectively). Re-PCI for any cause occurred in 31.5% of patients and shows an increased risk for three-lesion stenting (HR 4.3; CI 95% 2.873-6.376; p < 0.001) and the treatment of bifurcation with two stents (HR 1.6; 95% CI 1.051-2.414; p = 0.028). Stent thrombosis rate at the 5-year FU was 4.4% (1.3% definite; 0.9% probable; 2.1% possible), including a 1.7% rate of very-late thrombosis. The stent length superior to 40 mm was not associated with poor outcomes (all-cause death p = 0.349; cardiovascular death p = 0.855; MI p = 0.691; re-PCI p = 0.234; TLR p = 0.805; TVR p = 0.087; ST p = 0.189).
Conclusion: At an FU of longer than five years, patients treated with stents longer than 30 mm in their LAD showed acceptable procedural results but poor outcomes.
Keywords: 5-year FU; PCI; left anterior descending; long stenting; very long-term follow-up (FU).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Cone Flare Crush Modified-T (CFCT) stenting technique for coronary artery bifurcation lesions.Int J Cardiol Heart Vasc. 2020 Sep 25;30:100643. doi: 10.1016/j.ijcha.2020.100643. eCollection 2020 Oct. Int J Cardiol Heart Vasc. 2020. PMID: 33015315 Free PMC article.
-
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005. JACC Cardiovasc Interv. 2013. PMID: 24050859
-
Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).Am J Cardiol. 2017 Feb 1;119(3):355-364. doi: 10.1016/j.amjcard.2016.10.033. Epub 2016 Oct 31. Am J Cardiol. 2017. PMID: 27887688
-
Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.Catheter Cardiovasc Interv. 2022 Nov;100 Suppl 1:S44-S56. doi: 10.1002/ccd.30416. Epub 2022 Oct 17. Catheter Cardiovasc Interv. 2022. PMID: 36251325
-
Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.Cardiovasc Revasc Med. 2019 Sep;20(9):758-767. doi: 10.1016/j.carrev.2018.11.013. Epub 2018 Nov 22. Cardiovasc Revasc Med. 2019. PMID: 30503811
References
-
- Head S.J., Milojevic M., Daemen J., Ahn J.-M., Boersma E., Christiansen E.H., Domanski M.J., Farkouh M.E., Flather M., Fuster V., et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: A pooled analysis of individual patient data. Lancet. 2018;391:939–948. doi: 10.1016/S0140-6736(18)30423-9. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous